How European countries prevent and communicate on Hantavirus infection, ECDC study
Prompted by the increase of hantavirus activity in Europe observed in 2012, ECDC report reviewed the preventive measures and communication strategies in European countries.
Surveillance, prevention and control of dengue in Madeira: lessons learnt after the 2013 ECDC mission
New report provides recommendations for surveillance, prevention and control of dengue in Madeira, following the ECDC mission to Madeira in March 2013.
World Health Day 2014: focusing on vector-borne diseases in Europe
2014, the focus of World Health day was on vector-borne diseases. World Health Day is a worldwide initiative celebrated every year on 7 April to mark the anniversary of the founding of the World Health Organization (WHO) in 1948.
New ECDC protocols for surveillance of healthcare-associated infections: targeted surveillance is an essential tool for control and prevention
Today, ECDC’s Healthcare-associated Infections Surveillance Network (HAI-Net) publishes a new version of the software application HelicsWin.Net.
Investing in HIV response essential to curb on-going HIV transmission in Europe.Archived
New data for 2011 show that more than 121 000 new HIV cases were reported in the WHO European Region, including more than 28 000 new infections in the European Union and the European Economic Area (EU/EEA), indicating an increase for the whole Region compared to the previous year1.
Taking stock: where does Europe stand in the elimination of hepatitis B and C?
In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, the authors take a closer look how Europe is doing according to the ten indicators and targets outlined in this plan. In short: Europe still has some way to go if it wants to eliminate viral hepatitis by 2030.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
World AIDS Day 2017
One in 2 people living with HIV are diagnosed late in the course of their infection. So late, that two out of three people with AIDS in the EU/EEA receive their diagnosis within only three months of discovering they had HIV. For World AIDS Day 2017, ECDC highlighted the problem of late diagnosis and the need for diversifying HIV testing approaches.